Evaxion announces business update and full year 2024 financial results
COPENHAGEN, Denmark, April 1, 2025 - Evaxion Biotech A/S ( NASDAQ: EVAX ) ( "Evaxion" ) , a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business update and announces full year 2024 financial results.
Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D.
PRINCETON, N.J., April 01, 2025 ( GLOBE NEWSWIRE ) -- Sonnet BioTherapeutics Holdings, Inc. ( NASDAQ:SONN ) ( the "Company" or "Sonnet" ) , a clinical-stage company developing immunotherapeutic drugs targeted to the tumor microenvironment ( TME ) , today announced with deep and profound sadness ...
Watsco Declares $3.00 Quarterly Dividend, Reflects 11% Increase to an Annual Rate of $12.00 Per Share - Watsco ( NYSE:WSO )
MIAMI, April 01, 2025 ( GLOBE NEWSWIRE ) -- Watsco, Inc.'s WSO Board of Directors has declared a regular quarterly cash dividend of $3.00 on each outstanding share of its Common and Class B common stock payable on April 30, 2025 to shareholders of record at the close of business on April 15, ...
ISS Recommends Shareholders Vote "FOR" Amplify's Proposed Acquisition of Assets from Juniper Capital
HOUSTON, April 01, 2025 ( GLOBE NEWSWIRE ) -- Amplify Energy Corp. ( NYSE: AMPY ) ( "Amplify" or the "Company" ) announced that Institutional Shareholder Services ( "ISS" ) , a leading independent proxy advisory firm, has recommended that shareholders vote "FOR" the Company's proposed merger ...
LeddarTech Enters Into Further Amendments to Credit Facility and Bridge Financing Offer and Announces Receipt of Nasdaq Deficiency Notice - LeddarTech Holdings ( NASDAQ:LDTC )
QUEBEC CITY, Canada, April 01, 2025 ( GLOBE NEWSWIRE ) -- LeddarTech® Holdings Inc. ( "LeddarTech" ) LDTC, an automotive software company that provides patented disruptive AI-powered low-level sensor fusion and perception software technology, LeddarVision™, today announced that it has entered ...
Context Therapeutics to Participate in Upcoming Investor Conferences
PHILADELPHIA, April 01, 2025 ( GLOBE NEWSWIRE ) -- Context Therapeutics Inc. ( "Context" or the "Company" ) ( Nasdaq: CNTX ) , a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced its participation in several upcoming ...
LeddarTech Enters Into Further Amendments to Credit Facility and Bridge Financing Offer and Announces Receipt of Nasdaq Deficiency Notice
QUEBEC CITY, Canada, April 01, 2025 ( GLOBE NEWSWIRE ) -- LeddarTech® Holdings Inc. ( "LeddarTech" ) ( Nasdaq: LDTC ) , an automotive software company that provides patented disruptive AI-powered low-level sensor fusion and perception software technology, LeddarVision™, today announced that it ...
Alibaba woos back DingTalk founder to lead office app's AI push
Chen Hang, who created the app in 2015, will return as DingTalk CEO as Alibaba plans to take a stake in the entrepreneur's start-up.
5 Stock Picks Last Month From Wall Street's Most Accurate Analysts - Acadia Healthcare Co ( NASDAQ:ACHC ) , Chewy ( NYSE:CHWY )
U.S. stocks settled mixed on Monday, with the Dow Jones index gaining more than 400 points during the session as investors assessed President Donald Trump's tariff plans. However, the Nasdaq settled lower on Monday as shares of Nvidia Corp. NVDA fell 1.2% and Tesla Inc. TSLA lost 1.7%.
Context Therapeutics to Participate in Upcoming Investor Conferences - Context Therapeutics ( NASDAQ:CNTX )
PHILADELPHIA, April 01, 2025 ( GLOBE NEWSWIRE ) -- Context Therapeutics Inc. ( "Context" or the "Company" ) CNTX, a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced its participation in several upcoming investor ...